(AP) - Isis Pharmaceuticals Inc. said Tuesday it closed the $175 million sale of its remaining stake in Ibis Biosciences to Abbott Laboratories....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Isis Pharmaceuticals closes $175 million sale of Ibis Biosciences to...
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account